The Aptamer Market: A Rapidly Expanding Frontier in Biotechnology
The aptamer market is experiencing unprecedented growth, positioning itself as one of the most promising sectors in biotechnology. The U.S. aptamer market size was exhibited at USD 920 million in 2024 and is projected to be worth around USD 8,330 million by 2034, poised to grow at a CAGR of 24.69% from 2025 to 2034. This explosive growth trajectory reflects the increasing recognition of aptamers as versatile molecular tools with transformative potential across diagnostics and therapeutics. Request a Sample: https://www.futurewiseresearch.com/contact.aspx?rpt=9117&type=requestsample What Are Aptamers? Aptamers are short single-stranded DNA or RNA oligonucleotides that can selectively bind to small molecular ligands or protein targets with high affinity and specificity, by acquiring unique three-dimensional structures. Often referred to as "chemical antibodies," aptamers are oligonucleotide sequences with a length of about 25–80 bases which have abilities to bind to...